ORL-1B

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameORL-1B
Drug Alias NameORL-1B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsBiotinidase Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrpha Labs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrpha Labs
Active IndicationsN/A
Inactive IndicationsBiotinidase Deficiency

Other Information

ATC CodeN/A
Related LinksN/A